Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shruti Saxena-Beem

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Rheumatology|November 8, 2022
Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapyAmanda Lusa, Carolina Alvarez, Shruti Saxena Beem, et al.
Lupus (Los Angeles)|February 14, 2020
Clinician's Perceptions of a CME Activity to Increase Knowledge of Vaccination in Adults with Chronic Inflammatory ConditionsSaira Z Sheikh, Edward G A Iglesia, Matthew Underwood, et al.
Clinical and Translational Gastroenterology|September 12, 2024
Multiple Gastrointestinal Immune-Related Adverse Events From Immune Checkpoint Inhibitor TherapyTrevor S Barlowe, Shruti Saxena-Beem, Rumey C Ishizawar, et al.
Cancers|June 26, 2025
Neutrophil to Lymphocyte Ratio as a Biomarker for the Prediction of Cancer Outcomes and Immune-Related Adverse Events in a CTLA-4-Treated PopulationMichael M Cunningham, Rachel Romero, Carolina Alvarez, et al.
Chest|February 23, 2021
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer: Real-World Incidence, Risk Factors, and Management Practices Across Six Health Care Centers in North CarolinaWilliam T Atchley, Carolina Alvarez, Shruti Saxena-Beem, et al.
Chest|March 8, 2022
ResponseWilliam T Atchley, Carolina Alvarez, Shruti Saxena-Beem, et al.
Lupus|December 2, 2025
Exploring prefrontal alpha modulation as a mechanistic treatment target in lupus-associated depression: A transcranial alternating current stimulation studyMagdalena Camenzind, Tobias Schwippel, Shruti Saxena-Beem, et al.
ACR Open Rheumatology|October 31, 2022
Perceived Impact of the COVID-19 Pandemic on Physical Activity Among Adult Patients With Rheumatologic DiseaseShruti Saxena-Beem, Teresa A Dickson, Tessa R Englund, et al.
BMC Rheumatology|June 17, 2021
Pilot study of an internet-based pain coping skills training program for patients with systemic Lupus ErythematosusKelli D Allen, Tyler Beauchamp, Christine Rini, et al.
JCI Insight|February 17, 2026
Reduced late endosome/lysosome function promotes SLE through chronic PI3k activity and SHP-1/SHIP-1 defectsSunAh Kang, Andrew J Monteith, Liubov Arbeeva, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Rheumatology|November 8, 2022
Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapyAmanda Lusa, Carolina Alvarez, Shruti Saxena Beem, et al.
Lupus (Los Angeles)|February 14, 2020
Clinician's Perceptions of a CME Activity to Increase Knowledge of Vaccination in Adults with Chronic Inflammatory ConditionsSaira Z Sheikh, Edward G A Iglesia, Matthew Underwood, et al.
Clinical and Translational Gastroenterology|September 12, 2024
Multiple Gastrointestinal Immune-Related Adverse Events From Immune Checkpoint Inhibitor TherapyTrevor S Barlowe, Shruti Saxena-Beem, Rumey C Ishizawar, et al.
Cancers|June 26, 2025
Neutrophil to Lymphocyte Ratio as a Biomarker for the Prediction of Cancer Outcomes and Immune-Related Adverse Events in a CTLA-4-Treated PopulationMichael M Cunningham, Rachel Romero, Carolina Alvarez, et al.
Chest|February 23, 2021
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer: Real-World Incidence, Risk Factors, and Management Practices Across Six Health Care Centers in North CarolinaWilliam T Atchley, Carolina Alvarez, Shruti Saxena-Beem, et al.
Chest|March 8, 2022
ResponseWilliam T Atchley, Carolina Alvarez, Shruti Saxena-Beem, et al.
Lupus|December 2, 2025
Exploring prefrontal alpha modulation as a mechanistic treatment target in lupus-associated depression: A transcranial alternating current stimulation studyMagdalena Camenzind, Tobias Schwippel, Shruti Saxena-Beem, et al.
ACR Open Rheumatology|October 31, 2022
Perceived Impact of the COVID-19 Pandemic on Physical Activity Among Adult Patients With Rheumatologic DiseaseShruti Saxena-Beem, Teresa A Dickson, Tessa R Englund, et al.
BMC Rheumatology|June 17, 2021
Pilot study of an internet-based pain coping skills training program for patients with systemic Lupus ErythematosusKelli D Allen, Tyler Beauchamp, Christine Rini, et al.
JCI Insight|February 17, 2026
Reduced late endosome/lysosome function promotes SLE through chronic PI3k activity and SHP-1/SHIP-1 defectsSunAh Kang, Andrew J Monteith, Liubov Arbeeva, et al.
Pageof 2